FindTrial
Sign In

Application of nalbuphine injection in elderly patients after laparoscopic hysterectomy in PCIA

Application of nalbuphine injection in elderly patients after laparoscopic hysterectomy in PCIA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015329
Enrollment
Unknown
Registered
2018-03-23
Start date
2018-03-26
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative pain control

Interventions

2:sufentanil
1:nalbuphine

Sponsors

Dept. of Anaesthesiology, Fujian Provincial Hospital Jinshan branch
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
65 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing laparoscopic hysterectomy; 2. ASA II or III, aged 65 to 75 years, with a weight of 45 to 75 kg; 3. Surgery duration < 2 hours.

Exclusion criteria

Exclusion criteria: 1. Mental illness and neurological diseases; 2. Cognitive function and language communication impairment; 3. History of chronic pain and history of chronic opioid analgesia

Design outcomes

Primary

MeasureTime frame
rest and active pain levels;—

Countries

China

Contacts

Public ContactYanqing Chen

Dept. of Anaesthesiology, Fujian Provincial Hospital Jinshan branch

sxd605@163.com+86 13314935073

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026